Source: mirceax/Getty Images

Zika Biomarkers Could Lead to Prenatal Diagnostic

A panel of Zika virus positive biomarkers may lead to a better understanding of how the infection in pregnancy leads to fetal abnormalities
Addressing analysts at the J.P. Morgan 37th Healthcare Conference on Monday

At J.P. Morgan Conference, Illumina CEO Talks $100 Genome, Tariffs, and NovaSeq

CEO Francis deSouza says Illumina’s top-of-the-line sequencer reached $1 billion in revenues in 2018, in its second year on the market
Source: p_saranya/Getty Images

GWAS Helps Uncover the Genomics of Mouth Ulcers

British researchers use UK Biobank data to identify areas of the genome associated with triggering mouth ulcers
Prostate cancer cells, illustration

Methylation Signature Distinguishes Aggressive from Manageable Prostate Cancer

Scientists identify a pattern of 17 epigenetic markers that distinguishes aggressive from manageable prostate cancer with up to 92% accuracy
Most medical conditions involve multiple genes that may interact with one another and with environmental factors. [Source: iStock / nicodemos]

Epigenetics Research Reveals a Range of Clinical Possibilities

Most medical conditions involve multiple genes that may interact with one another and with environmental factors.
Richard Gibbs

Bulk Sequencing: NIH’s All of US Research Program Awards $28.6 Million for Genome Centers

The NIH’s All of Us Research Program has awarded a total $28.6 million to establish three genome centers nationwide.
Finnish genetic testing and analyzing technology company Negen will use BC Platforms' genomic data management platform (pictured) toward the early risk assessment of common diseases. [Source: BC Platforms]

BC Platforms, Negen Partner on Early Disease Risk Assessment Tool

BC Platforms’ genomic data management platform would be integrated with Negen’s Genetic Risk Scoring tools
3D DNA strands on a technology abstract background

YourDNA, DNA ID Partner to Connect Rare Disease Patients and Researchers

A new partnership was just announced between YourDNA and DNA ID to connect rare disease patients to genetic researchers in a safe, secure, and...
Owlstone Medical's Lonestar gas analyzer (pictured with the ReCIVA breath sampler) will be studied in a clinical trial with Mayo Clinic assessing its effectiveness as a test for bowel preparation before colonoscopy. (Source: Owlstone Medical)

Owlstone Medical, Mayo Clinic Plan Trial of FAIMS Platform As Pre-Endoscopic Test

Partners to study Field Asymmetric Ion Mobility Spectrometer as a non-invasive test assessing adequacy of bowel prep before colonoscopies

NIPT Startup Cradle Genomics Closes $17.1M Series A Financing

A San Diego startup non-invasive prenatal test (NIPT) developer has raised $17.1 million in a Series A financing designed to support clinical development, corporate...
Scroll Up